Pureland Group

Pureland Group is a Singapore-based private investment firm specializing in healthcare and medical technology investments. The firm operates two primary investment portfolios: Fund I, which focuses on secondary markets with capital preservation as its core theme, and Fund II, an impact fund targeting medical technology venture investments.

Through its subsidiary, Pureland Venture, the firm invests in early-stage companies in the medical technology sector, emphasizing solutions that enhance patient care, save lives, and address supply-demand gaps in healthcare. The fund's mission is to bring medical solutions and savings to 100 million people globally, with a focus on sectors such as ophthalmology, cancer detection, radiotherapy, pregnancy care, point-of-care testing, premature birth, chronic diseases, and knee rehabilitation.

Pureland Venture's investment strategy centers on impact, scalability, governance, and profitability. The firm seeks to support founders and teams that demonstrate integrity, intelligence, and energy, aiming to back companies that bring new solutions to traditional problems in prevention, treatment, and medical efficiency. The fund leads or participates in both equity rounds and convertible note rounds, with a geographical footprint covering India, Taiwan, Hong Kong, Singapore, the United States, and the United Kingdom.